129 related articles for article (PubMed ID: 3944706)
1. Long-term endocrine sequelae after treatment of medulloblastoma: prospective study of growth and thyroid function.
Oberfield SE; Allen JC; Pollack J; New MI; Levine LS
J Pediatr; 1986 Feb; 108(2):219-23. PubMed ID: 3944706
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
[TBL] [Abstract][Full Text] [Related]
3. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma.
Heikens J; Michiels EM; Behrendt H; Endert E; Bakker PJ; Fliers E
Eur J Cancer; 1998 Sep; 34(10):1592-7. PubMed ID: 9893634
[TBL] [Abstract][Full Text] [Related]
4. Endocrine sequelae beyond 10 years in survivors of medulloblastoma.
Uday S; Murray RD; Picton S; Chumas P; Raju M; Chandwani M; Alvi S
Clin Endocrinol (Oxf); 2015 Nov; 83(5):663-70. PubMed ID: 25952583
[TBL] [Abstract][Full Text] [Related]
5. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy.
Xu W; Janss A; Packer RJ; Phillips P; Goldwein J; Moshang T
Neuro Oncol; 2004 Apr; 6(2):113-8. PubMed ID: 15134625
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy.
Ricardi U; Corrias A; Einaudi S; Genitori L; Sandri A; di Montezemolo LC; Besenzon L; Madon E; Urgesi A
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1287-94. PubMed ID: 11483340
[TBL] [Abstract][Full Text] [Related]
7. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma.
Abayomi OK; Sadeghi-Nejad A
Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):945-8. PubMed ID: 3721935
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
9. Long-term endocrine sequelae after surgery, radiotherapy, and chemotherapy in children with medulloblastoma.
Pasqualini T; Diez B; Domene H; Escobar ME; Gruñeiro L; Heinrich JJ; Martinez A; Iorcansky S; Sackmann-Muriel F; Rivarola M
Cancer; 1987 Feb; 59(4):801-6. PubMed ID: 3802038
[TBL] [Abstract][Full Text] [Related]
10. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
11. The effects of adjuvant chemotherapy on growth in children with medulloblastoma.
Olshan JS; Gubernick J; Packer RJ; D'Angio GJ; Goldwein JW; Willi SM; Moshang T
Cancer; 1992 Oct; 70(7):2013-7. PubMed ID: 1525779
[TBL] [Abstract][Full Text] [Related]
12. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapeutic management of medulloblastoma.
Paulino AC
Oncology (Williston Park); 1997 Jun; 11(6):813-23; discussion 823, 827-8, 831. PubMed ID: 9189939
[TBL] [Abstract][Full Text] [Related]
14. Growth and endocrine function after treatment for medulloblastoma.
Brown IH; Lee TJ; Eden OB; Bullimore JA; Savage DC
Arch Dis Child; 1983 Sep; 58(9):722-7. PubMed ID: 6414386
[TBL] [Abstract][Full Text] [Related]
15. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
16. [Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy].
Röttinger EM
Strahlenther Onkol; 1995 Apr; 171(4):247-8. PubMed ID: 7740416
[No Abstract] [Full Text] [Related]
17. Medulloblastoma--challenges in radiation therapy and the addition of chemotherapy.
Kun LE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):261-3. PubMed ID: 10661329
[No Abstract] [Full Text] [Related]
18. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.
Gajjar A; Mulhern RK; Heideman RL; Sanford RA; Douglass EC; Kovnar EH; Langston JA; Jenkins JJ; Kun LE
J Clin Oncol; 1994 Jun; 12(6):1212-6. PubMed ID: 8201384
[TBL] [Abstract][Full Text] [Related]
19. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours.
Schmiegelow M
Dan Med Bull; 2006 Aug; 53(3):326-41. PubMed ID: 17092452
[No Abstract] [Full Text] [Related]
20. Long-term effects of treatment on endocrine function in children with brain tumors.
Duffner PK; Cohen ME; Anderson SW; Voorhess ML; MacGillivray MH; Panahon A; Brecher ML
Ann Neurol; 1983 Nov; 14(5):528-32. PubMed ID: 6651240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
